NARA Discovery
Article Details
← Back to Search Results
Journal Article

Efficacy of an Inactivated Bacterin Vaccine Against Emerging Streptococcus dysgalactiae in Channel Catfish ( Ictalurus punctatus )

Brent M. Vuglar; Krishna P. Singha; Craig A. Shoemaker; Benjamin H. Beck; Taylor I. Heckman; Jason W. Abernathy; Julio C. García; Eric Peatman; Timothy J. Bruce
Journal of Fish Diseases · 2026

Abstract

Lancefield Group C Streptococcus dysgalactiae recently emerged as a catfish pathogen in the US. Reports from hatcheries suggest S. dysgalactiae causes substantial broodfish loss. We aimed to develop a challenge model and evaluate vaccine efficacy against S. dysgalactiae in juvenile channel catfish ( Ictalurus punctatus ). Three S. dysgalactiae (14–1, 14–24 and 14–25) isolates were tested for virulence. Intracoelomic (IC) injection demonstrated S. dysgalactiae 14–1 was the most virulent. Reisolated 14–1 was used to develop a formalin‐killed cell (FKC) vaccine. Catfish (200) were immunized via IC injection of 100 μL FKC with adjuvant (1:1 v/v), and another 200 catfish were sham vaccinated. Five fish from each group were bled for antibody titre every 14 days. At 28 and 56 days post‐vaccination (dpv), subsets of both groups were challenged with S. dysgalactiae via IC injection (200 μL/fish) in triplicate (20 fish/tank). Cumulative percent mortality was significantly ( p S. dysgalactiae bacterin induced humoral immunity and protected juvenile catfish. Future studies are planned to evaluate this bacterin in broodfish.

Bibliographic Information

JournalJournal of Fish Diseases
PublisherWiley
Publication Date2026-07-12
Publication Year2026
Document TypeJournal Article
Print ISSN0140-7775
eISSN1365-2761
DOI10.1111/jfd.70243
SubjectGeneral Aquaculture, Fisheries & Fish Science

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/13652761
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.